2024-2028年細胞表面標誌物的全球市場
市場調查報告書
商品編碼
1366470

2024-2028年細胞表面標誌物的全球市場

Global Cell Surface Markers Market 2024-2028

出版日期: | 出版商: TechNavio | 英文 166 Pages | 訂單完成後即時交付

價格

預計2023-2028年細胞表面標誌物市場將成長140.6895億美元,預測期內年複合成長率為8.25%。

該報告包括對細胞表面標誌物市場的總體分析、市場規模和預測、趨勢、成長促進因素、課題以及涵蓋約 25 家供應商的供應商分析。

該報告提供了對當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。該市場是由 COVID-19 大流行的影響、對精準醫療的需求不斷增加以及診斷的使用不斷增加所推動的。

市場範圍
基準年 2022年
結束年份 2027年
預測期 2023-2027
成長動力 加速度
與前一年同期比較 7.83%
年複合成長率 8.25%
增量 14,068,950,000 美元

該報告指出,癌症檢測中擴大使用診斷技術是未來年度推動細胞表面標誌物市場成長的關鍵要素之一。此外,流式細胞儀技術的日益普及以及人工智慧和機器學習的整合將帶來巨大的市場需求。

目錄

第1章 執行摘要

  • 市場概況

第2章 市場形勢

  • 市場生態系統

第3章 市場規模

  • 市場定義
  • 區隔市場分析
  • 2023 年市場規模
  • 2023-2028年市場預測

第4章 市場規模實績

  • 全球細胞表面標誌物市場 2018-2022
  • 2018-2022 年依用途分類的區隔市場分析
  • 2018-2022 年依產品區隔分析
  • 2018-2022 年區域區隔分析
  • 2018-2022 年國家區隔分析

第5章 五力分析

  • 五力摘要
  • 買方議價能力
  • 供應商的議價能力
  • 新進入者的威脅
  • 替代的威脅
  • 競爭威脅
  • 市場狀況

第6章 市場區隔:依用途

  • 區隔市場
  • 比較:依用途
  • 疾病診斷:2023-2028年市場規模及預測
  • 研究與藥物研發:2023-2028 年市場規模與預測
  • 市場機會:依用途

第7章 市場區隔:依產品

  • 區隔市場
  • 比較:依產品
  • 抗體:2023-2028 年市場規模與預測
  • PCR陣列:2023-2028年市場規模及預測
  • 市場機會:依產品分類

第8章 客戶形勢

  • 客戶形勢概覽

第9章 地區形勢

  • 區域區隔
  • 區域比較
  • 北美:2023-2028 年市場規模與預測
  • 歐洲:2023-2028 年市場規模與預測
  • 亞洲:2023-2028年市場規模與預測
  • 世界其他地區:2023-2028 年市場規模與預測
  • 美國:2023-2028 年市場規模與預測
  • 中國:2023-2028年市場規模及預測
  • 德國:2023-2028 年市場規模與預測
  • 法國:2023-2028年市場規模與預測
  • 英國:2023-2028 年市場規模與預測
  • 市場機會:依地區

第10章 促進因素、問題與趨勢

  • 市場促進因素
  • 市場課題
  • 促進因素和課題的影響
  • 市場趨勢

第11章供應商形勢

  • 概述
  • 供應商形勢
  • 混亂的情況
  • 產業風險

第12章供應商分析

  • 交易廠商
  • 供應商市場定位
  • Abbott Laboratories
  • Abcam plc
  • Agilent Technologies Inc.
  • Becton Dickinson and Co.
  • Bio Rad Laboratories Inc.
  • Danaher Corp.
  • DiaSorin SpA
  • F. Hoffmann La Roche Ltd.
  • Grifols SA
  • Johnson and Johnson
  • PerkinElmer Inc.
  • QIAGEN NV
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.
  • Werfenlife SA

第13章附錄

Product Code: IRTNTR71681

The cell surface markers market is forecasted to grow by USD 14068.95 mn during 2023-2028, accelerating at a CAGR of 8.25% during the forecast period. The report on the cell surface markers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by COVID-19 pandemic impact, increasing demand for precision medicine, and increasing use of diagnostics.

Technavio's cell surface markers market is segmented as below:

Market Scope
Base Year2022
End Year2027
Series Year2023-2027
Growth MomentumAccelerate
YOY 20237.83%
CAGR8.25%
Incremental Value$14068.95mn

By Application

  • Disease diagnosis
  • Research
  • drug discovery

By Product

  • Antibody
  • PCR array

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the increased use of diagnostics in cancer detection as one of the prime reasons driving the cell surface markers market growth during the next few years. Also, increasing popularity of flow cytometry technique and integration of artificial intelligence and machine learning will lead to sizable demand in the market.

The report on the cell surface markers market covers the following areas:

  • Cell surface markers market sizing
  • Cell surface markers market forecast
  • Cell surface markers market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cell surface markers market vendors that include Abbott Laboratories, Abcam plc, Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio Techne Corp., Cell Signaling Technology Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., GenScript Biotech Corp., Grifols SA, IVD Medical Holding Ltd., Johnson and Johnson, PerkinElmer Inc., QIAGEN NV, Siemens Healthineers AG, Sysmex Corp., Thermo Fisher Scientific Inc., and Werfenlife SA. Also, the cell surface markers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
  • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global cell surface markers market 2018 - 2022
  • Exhibit 18: Historic Market Size - Data Table on global cell surface markers market 2018 - 2022 ($ million)
  • 4.2 Application Segment Analysis 2018 - 2022
  • Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
  • 4.3 Product Segment Analysis 2018 - 2022
  • Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
  • 4.4 Geography Segment Analysis 2018 - 2022
  • Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • 4.5 Country Segment Analysis 2018 - 2022
  • Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

  • 6.1 Market segments
  • Exhibit 30: Chart on Application - Market share 2023-2028 (%)
  • Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
  • 6.2 Comparison by Application
  • Exhibit 32: Chart on Comparison by Application
  • Exhibit 33: Data Table on Comparison by Application
  • 6.3 Disease diagnosis - Market size and forecast 2023-2028
  • Exhibit 34: Chart on Disease diagnosis - Market size and forecast 2023-2028 ($ million)
  • Exhibit 35: Data Table on Disease diagnosis - Market size and forecast 2023-2028 ($ million)
  • Exhibit 36: Chart on Disease diagnosis - Year-over-year growth 2023-2028 (%)
  • Exhibit 37: Data Table on Disease diagnosis - Year-over-year growth 2023-2028 (%)
  • 6.4 Research and drug discovery - Market size and forecast 2023-2028
  • Exhibit 38: Chart on Research and drug discovery - Market size and forecast 2023-2028 ($ million)
  • Exhibit 39: Data Table on Research and drug discovery - Market size and forecast 2023-2028 ($ million)
  • Exhibit 40: Chart on Research and drug discovery - Year-over-year growth 2023-2028 (%)
  • Exhibit 41: Data Table on Research and drug discovery - Year-over-year growth 2023-2028 (%)
  • 6.5 Market opportunity by Application
  • Exhibit 42: Market opportunity by Application ($ million)
  • Exhibit 43: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Product

  • 7.1 Market segments
  • Exhibit 44: Chart on Product - Market share 2023-2028 (%)
  • Exhibit 45: Data Table on Product - Market share 2023-2028 (%)
  • 7.2 Comparison by Product
  • Exhibit 46: Chart on Comparison by Product
  • Exhibit 47: Data Table on Comparison by Product
  • 7.3 Antibody - Market size and forecast 2023-2028
  • Exhibit 48: Chart on Antibody - Market size and forecast 2023-2028 ($ million)
  • Exhibit 49: Data Table on Antibody - Market size and forecast 2023-2028 ($ million)
  • Exhibit 50: Chart on Antibody - Year-over-year growth 2023-2028 (%)
  • Exhibit 51: Data Table on Antibody - Year-over-year growth 2023-2028 (%)
  • 7.4 PCR array - Market size and forecast 2023-2028
  • Exhibit 52: Chart on PCR array - Market size and forecast 2023-2028 ($ million)
  • Exhibit 53: Data Table on PCR array - Market size and forecast 2023-2028 ($ million)
  • Exhibit 54: Chart on PCR array - Year-over-year growth 2023-2028 (%)
  • Exhibit 55: Data Table on PCR array - Year-over-year growth 2023-2028 (%)
  • 7.5 Market opportunity by Product
  • Exhibit 56: Market opportunity by Product ($ million)
  • Exhibit 57: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 9.2 Geographic comparison
  • Exhibit 61: Chart on Geographic comparison
  • Exhibit 62: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
  • Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Europe - Market size and forecast 2023-2028
  • Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.5 Asia - Market size and forecast 2023-2028
  • Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
  • Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 China - Market size and forecast 2023-2028
  • Exhibit 83: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibit 84: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibit 85: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibit 86: Data Table on China - Year-over-year growth 2023-2028 (%)
  • 9.9 Germany - Market size and forecast 2023-2028
  • Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 9.10 France - Market size and forecast 2023-2028
  • Exhibit 91: Chart on France - Market size and forecast 2023-2028 ($ million)
  • Exhibit 92: Data Table on France - Market size and forecast 2023-2028 ($ million)
  • Exhibit 93: Chart on France - Year-over-year growth 2023-2028 (%)
  • Exhibit 94: Data Table on France - Year-over-year growth 2023-2028 (%)
  • 9.11 UK - Market size and forecast 2023-2028
  • Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 99: Market opportunity By Geographical Landscape ($ million)
  • Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 101: Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 103: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 104: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 105: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 106: Matrix on vendor position and classification
  • 12.3 Abbott Laboratories
  • Exhibit 107: Abbott Laboratories - Overview
  • Exhibit 108: Abbott Laboratories - Business segments
  • Exhibit 109: Abbott Laboratories - Key news
  • Exhibit 110: Abbott Laboratories - Key offerings
  • Exhibit 111: Abbott Laboratories - Segment focus
  • 12.4 Abcam plc
  • Exhibit 112: Abcam plc - Overview
  • Exhibit 113: Abcam plc - Product / Service
  • Exhibit 114: Abcam plc - Key news
  • Exhibit 115: Abcam plc - Key offerings
  • 12.5 Agilent Technologies Inc.
  • Exhibit 116: Agilent Technologies Inc. - Overview
  • Exhibit 117: Agilent Technologies Inc. - Business segments
  • Exhibit 118: Agilent Technologies Inc. - Key offerings
  • Exhibit 119: Agilent Technologies Inc. - Segment focus
  • 12.6 Becton Dickinson and Co.
  • Exhibit 120: Becton Dickinson and Co. - Overview
  • Exhibit 121: Becton Dickinson and Co. - Business segments
  • Exhibit 122: Becton Dickinson and Co. - Key news
  • Exhibit 123: Becton Dickinson and Co. - Key offerings
  • Exhibit 124: Becton Dickinson and Co. - Segment focus
  • 12.7 Bio Rad Laboratories Inc.
  • Exhibit 125: Bio Rad Laboratories Inc. - Overview
  • Exhibit 126: Bio Rad Laboratories Inc. - Business segments
  • Exhibit 127: Bio Rad Laboratories Inc. - Key offerings
  • Exhibit 128: Bio Rad Laboratories Inc. - Segment focus
  • 12.8 Danaher Corp.
  • Exhibit 129: Danaher Corp. - Overview
  • Exhibit 130: Danaher Corp. - Business segments
  • Exhibit 131: Danaher Corp. - Key news
  • Exhibit 132: Danaher Corp. - Key offerings
  • Exhibit 133: Danaher Corp. - Segment focus
  • 12.9 DiaSorin SpA
  • Exhibit 134: DiaSorin SpA - Overview
  • Exhibit 135: DiaSorin SpA - Business segments
  • Exhibit 136: DiaSorin SpA - Key news
  • Exhibit 137: DiaSorin SpA - Key offerings
  • Exhibit 138: DiaSorin SpA - Segment focus
  • 12.10 F. Hoffmann La Roche Ltd.
  • Exhibit 139: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 140: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 141: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 142: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 143: F. Hoffmann La Roche Ltd. - Segment focus
  • 12.11 Grifols SA
  • Exhibit 144: Grifols SA - Overview
  • Exhibit 145: Grifols SA - Business segments
  • Exhibit 146: Grifols SA - Key offerings
  • Exhibit 147: Grifols SA - Segment focus
  • 12.12 Johnson and Johnson
  • Exhibit 148: Johnson and Johnson - Overview
  • Exhibit 149: Johnson and Johnson - Business segments
  • Exhibit 150: Johnson and Johnson - Key news
  • Exhibit 151: Johnson and Johnson - Key offerings
  • Exhibit 152: Johnson and Johnson - Segment focus
  • 12.13 PerkinElmer Inc.
  • Exhibit 153: PerkinElmer Inc. - Overview
  • Exhibit 154: PerkinElmer Inc. - Business segments
  • Exhibit 155: PerkinElmer Inc. - Key news
  • Exhibit 156: PerkinElmer Inc. - Key offerings
  • Exhibit 157: PerkinElmer Inc. - Segment focus
  • 12.14 QIAGEN NV
  • Exhibit 158: QIAGEN NV - Overview
  • Exhibit 159: QIAGEN NV - Product / Service
  • Exhibit 160: QIAGEN NV - Key news
  • Exhibit 161: QIAGEN NV - Key offerings
  • 12.15 Sysmex Corp.
  • Exhibit 162: Sysmex Corp. - Overview
  • Exhibit 163: Sysmex Corp. - Business segments
  • Exhibit 164: Sysmex Corp. - Key offerings
  • Exhibit 165: Sysmex Corp. - Segment focus
  • 12.16 Thermo Fisher Scientific Inc.
  • Exhibit 166: Thermo Fisher Scientific Inc. - Overview
  • Exhibit 167: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 168: Thermo Fisher Scientific Inc. - Key news
  • Exhibit 169: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 170: Thermo Fisher Scientific Inc. - Segment focus
  • 12.17 Werfenlife SA
  • Exhibit 171: Werfenlife SA - Overview
  • Exhibit 172: Werfenlife SA - Product / Service
  • Exhibit 173: Werfenlife SA - Key offerings

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 174: Inclusions checklist
  • Exhibit 175: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 176: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 177: Research methodology
  • Exhibit 178: Validation techniques employed for market sizing
  • Exhibit 179: Information sources
  • 13.5 List of abbreviations
  • Exhibit 180: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Application
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits18: Historic Market Size - Data Table on global cell surface markers market 2018 - 2022 ($ million)
  • Exhibits19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
  • Exhibits20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
  • Exhibits23: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits29: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits30: Chart on Application - Market share 2023-2028 (%)
  • Exhibits31: Data Table on Application - Market share 2023-2028 (%)
  • Exhibits32: Chart on Comparison by Application
  • Exhibits33: Data Table on Comparison by Application
  • Exhibits34: Chart on Disease diagnosis - Market size and forecast 2023-2028 ($ million)
  • Exhibits35: Data Table on Disease diagnosis - Market size and forecast 2023-2028 ($ million)
  • Exhibits36: Chart on Disease diagnosis - Year-over-year growth 2023-2028 (%)
  • Exhibits37: Data Table on Disease diagnosis - Year-over-year growth 2023-2028 (%)
  • Exhibits38: Chart on Research and drug discovery - Market size and forecast 2023-2028 ($ million)
  • Exhibits39: Data Table on Research and drug discovery - Market size and forecast 2023-2028 ($ million)
  • Exhibits40: Chart on Research and drug discovery - Year-over-year growth 2023-2028 (%)
  • Exhibits41: Data Table on Research and drug discovery - Year-over-year growth 2023-2028 (%)
  • Exhibits42: Market opportunity by Application ($ million)
  • Exhibits43: Data Table on Market opportunity by Application ($ million)
  • Exhibits44: Chart on Product - Market share 2023-2028 (%)
  • Exhibits45: Data Table on Product - Market share 2023-2028 (%)
  • Exhibits46: Chart on Comparison by Product
  • Exhibits47: Data Table on Comparison by Product
  • Exhibits48: Chart on Antibody - Market size and forecast 2023-2028 ($ million)
  • Exhibits49: Data Table on Antibody - Market size and forecast 2023-2028 ($ million)
  • Exhibits50: Chart on Antibody - Year-over-year growth 2023-2028 (%)
  • Exhibits51: Data Table on Antibody - Year-over-year growth 2023-2028 (%)
  • Exhibits52: Chart on PCR array - Market size and forecast 2023-2028 ($ million)
  • Exhibits53: Data Table on PCR array - Market size and forecast 2023-2028 ($ million)
  • Exhibits54: Chart on PCR array - Year-over-year growth 2023-2028 (%)
  • Exhibits55: Data Table on PCR array - Year-over-year growth 2023-2028 (%)
  • Exhibits56: Market opportunity by Product ($ million)
  • Exhibits57: Data Table on Market opportunity by Product ($ million)
  • Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits59: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits61: Chart on Geographic comparison
  • Exhibits62: Data Table on Geographic comparison
  • Exhibits63: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits65: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits66: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits69: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits73: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits79: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits80: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits81: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits82: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits83: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits84: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits85: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits86: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits89: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits91: Chart on France - Market size and forecast 2023-2028 ($ million)
  • Exhibits92: Data Table on France - Market size and forecast 2023-2028 ($ million)
  • Exhibits93: Chart on France - Year-over-year growth 2023-2028 (%)
  • Exhibits94: Data Table on France - Year-over-year growth 2023-2028 (%)
  • Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits99: Market opportunity By Geographical Landscape ($ million)
  • Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits101: Impact of drivers and challenges in 2023 and 2028
  • Exhibits102: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits103: Overview on factors of disruption
  • Exhibits104: Impact of key risks on business
  • Exhibits105: Vendors covered
  • Exhibits106: Matrix on vendor position and classification
  • Exhibits107: Abbott Laboratories - Overview
  • Exhibits108: Abbott Laboratories - Business segments
  • Exhibits109: Abbott Laboratories - Key news
  • Exhibits110: Abbott Laboratories - Key offerings
  • Exhibits111: Abbott Laboratories - Segment focus
  • Exhibits112: Abcam plc - Overview
  • Exhibits113: Abcam plc - Product / Service
  • Exhibits114: Abcam plc - Key news
  • Exhibits115: Abcam plc - Key offerings
  • Exhibits116: Agilent Technologies Inc. - Overview
  • Exhibits117: Agilent Technologies Inc. - Business segments
  • Exhibits118: Agilent Technologies Inc. - Key offerings
  • Exhibits119: Agilent Technologies Inc. - Segment focus
  • Exhibits120: Becton Dickinson and Co. - Overview
  • Exhibits121: Becton Dickinson and Co. - Business segments
  • Exhibits122: Becton Dickinson and Co. - Key news
  • Exhibits123: Becton Dickinson and Co. - Key offerings
  • Exhibits124: Becton Dickinson and Co. - Segment focus
  • Exhibits125: Bio Rad Laboratories Inc. - Overview
  • Exhibits126: Bio Rad Laboratories Inc. - Business segments
  • Exhibits127: Bio Rad Laboratories Inc. - Key offerings
  • Exhibits128: Bio Rad Laboratories Inc. - Segment focus
  • Exhibits129: Danaher Corp. - Overview
  • Exhibits130: Danaher Corp. - Business segments
  • Exhibits131: Danaher Corp. - Key news
  • Exhibits132: Danaher Corp. - Key offerings
  • Exhibits133: Danaher Corp. - Segment focus
  • Exhibits134: DiaSorin SpA - Overview
  • Exhibits135: DiaSorin SpA - Business segments
  • Exhibits136: DiaSorin SpA - Key news
  • Exhibits137: DiaSorin SpA - Key offerings
  • Exhibits138: DiaSorin SpA - Segment focus
  • Exhibits139: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits140: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits141: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits142: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits143: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits144: Grifols SA - Overview
  • Exhibits145: Grifols SA - Business segments
  • Exhibits146: Grifols SA - Key offerings
  • Exhibits147: Grifols SA - Segment focus
  • Exhibits148: Johnson and Johnson - Overview
  • Exhibits149: Johnson and Johnson - Business segments
  • Exhibits150: Johnson and Johnson - Key news
  • Exhibits151: Johnson and Johnson - Key offerings
  • Exhibits152: Johnson and Johnson - Segment focus
  • Exhibits153: PerkinElmer Inc. - Overview
  • Exhibits154: PerkinElmer Inc. - Business segments
  • Exhibits155: PerkinElmer Inc. - Key news
  • Exhibits156: PerkinElmer Inc. - Key offerings
  • Exhibits157: PerkinElmer Inc. - Segment focus
  • Exhibits158: QIAGEN NV - Overview
  • Exhibits159: QIAGEN NV - Product / Service
  • Exhibits160: QIAGEN NV - Key news
  • Exhibits161: QIAGEN NV - Key offerings
  • Exhibits162: Sysmex Corp. - Overview
  • Exhibits163: Sysmex Corp. - Business segments
  • Exhibits164: Sysmex Corp. - Key offerings
  • Exhibits165: Sysmex Corp. - Segment focus
  • Exhibits166: Thermo Fisher Scientific Inc. - Overview
  • Exhibits167: Thermo Fisher Scientific Inc. - Business segments
  • Exhibits168: Thermo Fisher Scientific Inc. - Key news
  • Exhibits169: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibits170: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibits171: Werfenlife SA - Overview
  • Exhibits172: Werfenlife SA - Product / Service
  • Exhibits173: Werfenlife SA - Key offerings
  • Exhibits174: Inclusions checklist
  • Exhibits175: Exclusions checklist
  • Exhibits176: Currency conversion rates for US$
  • Exhibits177: Research methodology
  • Exhibits178: Validation techniques employed for market sizing
  • Exhibits179: Information sources
  • Exhibits180: List of abbreviations